المؤلفون: Antonella Fameli, Valerio Nardone, Mojtaba Shekarkar Azgomi, Giovanna Bianco, Claudia Gandolfo, Bianca Maria Oliva, Marika Monoriti, Rita Emilena Saladino, Antonella Falzea, Caterina Romeo, Natale Daniele Calandruccio, Domenico Azzarello, Rocco Giannicola, Luigi Pirtoli, Antonio Giordano, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Grazia Cusi, Luciano Mutti, Cirino Botta, Pierpaolo Correale

المساهمون: Fameli, Antonella, Nardone, Valerio, Shekarkar Azgomi, Mojtaba, Bianco, Giovanna, Gandolfo, Claudia, Oliva, Bianca Maria, Monoriti, Marika, Saladino, Rita Emilena, Falzea, Antonella, Romeo, Caterina, Calandruccio, Natale Daniele, Azzarello, Domenico, Giannicola, Rocco, Pirtoli, Luigi, Giordano, Antonio, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Cusi, Maria Grazia, Mutti, Luciano, Botta, Cirino, Correale, Pierpaolo, Fameli, A., Nardone, V., Shekarkar Azgomi, M., Bianco, G., Gandolfo, C., Oliva, B. M., Monoriti, M., Saladino, R. E., Falzea, A., Romeo, C., Calandruccio, N. D., Azzarello, D., Giannicola, R., Pirtoli, L., Giordano, A., Tassone, P., Tagliaferri, P., Cusi, M. G., Mutti, L., Botta, C., Correale, P.

المصدر: Frontiers in oncology. 12

مصطلحات موضوعية: immune checkpoint inhibitors, Cancer Research, immune system, NSCL, Oncology, bioinformatic, NSLC, flow cytometry, immune checkpoint inhibitor, NKT, bioinformatics, PD1

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac80d6dc7ca7dff0bf466c21262f9902Test
https://pubmed.ncbi.nlm.nih.gov/36185285Test

المؤلفون: Valerio Nardone, Rocco Giannicola, Giovanna Bianco, Diana Giannarelli, Paolo Tini, Pierpaolo Pastina, Antonia Consuelo Falzea, Sebastiano Macheda, Michele Caraglia, Amalia Luce, Silvia Zappavigna, Luciano Mutti, Luigi Pirtoli, Antonio Giordano, Pierpaolo Correale

المساهمون: Nardone, V., Giannicola, R., Bianco, G., Giannarelli, D., Tini, P., Pastina, P., Falzea, A. C., Macheda, S., Caraglia, M., Luce, A., Zappavigna, S., Mutti, L., Pirtoli, L., Giordano, A., Correale, P.

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, Durvalumab, Salvage therapy, Pembrolizumab, Gastroenterology, Procalcitonin, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, prognostic factors of response, medicine, cell death receptor, Lung cancer, programmed cell death ligand-1, RC254-282, Original Research, business.industry, bacterial infection, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, inflammatory markers, inflammatory marker, real-world salvage therapy, bacterial infections, immune-check point blockade, procalcitonin, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbc2d28bc8b055476a3a290898f44b4Test
https://pubmed.ncbi.nlm.nih.gov/34195086Test